Value of CoC Accreditation. The American College of Surgeons and The American Cancer Society Partners to Improve the Lives of Cancer Patients. The American Cancer Society funds the American College of Surgeons development of an approval program for cancer care clinic 1926.
The American Cancer Society funds the American College of Surgeons development of an approval program for cancer care clinic
The American Cancer Society funds the Cancer Physician Liaison programs to engage physicians in Commission on cancer accredited programs
The American College of Surgeons and the American Cancer Society start their second century of their partnership
The American College of Surgeons pilots the National Cancer Data Base, the largest repository of cancer patient date in the world
The American Cancer Society and the America College of Surgeons are the founding members of the American Joint Committee on Cancer to formulate and publish cancer classification systems and staging
Overlapping groups of physicians found both the American College ofsSurgeons and the American Cancer Society
The Commission on Cancer gratefully acknowledges the support of the American Cancer Society for their support of the National Cancer Data Base
50 national professional
CoC set Standards
Provide Rigorous Data
Demonstrates commitment to quality care.
Improved patient outcomes across all domains of cancer care.
Dedicated resources to provide the screening, prevention treatment and support services.
Use of data applications to serve as the basis for quality improvement.
THINK ABOUT HOW THESE BENEFITS HELP YOUR CANCER PROGRAM AND PATIENTS!
Affect cost; increase revenue; ensure compliance
Show improved outcomes; lower costs
Give tools, information and structure to deliver best care
Proof of concept; educate public; demonstrate value
Reassurance and information about quality of care
Focus on quality of care via performance metrics and quality improvement.
- Accountability & QI measures
- Genetic assessment and counseling
- Palliative care services
- Increase clinical trial accruals
- Prevention and early screening
- Studies of quality and improvements
- Public reporting of outcomes
- Patient navigation (2015)
- Psychosocial distress screening (2015)
- Survivorship care plan (2015)
Around 1500 CoC-accredited cancer programs in the US and Puerto Rico
Provides feedback to:
Improve the quality of data across several disease sites.
Foster pre-emptive awareness to the importance of charting and coding accuracy.
Improve clinical management and coordination of patient care in the multidisciplinary setting.
Updated CP3R Report includes several modifications:
For 2014 surveys, cases diagnosed in 2010 and 2011 are reviewed (Standards 4.4 and 4.5).
CP3R update involves data submitted during 2012 and 2013 NCDB “Calls for Data”.
Allows expedited data entry of a critical items specifically relevant to anticipated standard of care treatments.
Enables data reporting on patients concurrently.
Shows up-to-date concordance rates relative to other programs.
Provides hospitals timely notification of treatment expectations allowing intervention (e.g. transportation) when patients have not received all components of treatment.
Generates Treatment Summaries.
765 participating sites
~ 54% of CoC Accredited Institutions
Identify patients who are at risk of “slipping through the cracks”.
Encourages collection of adjuvant treatment information and assists with the prevention of delay patients’ treatment.
Compares your performance rates with other participating cancer programs; and performance over time.
Year-to-date performance dashboards
Online prospective alerts
Emailed monthly alert reports
Patient Rx summary report
Adjuvant chemotherapy for lymph node positive
At least 12 lymph nodes are removed and examined
Radiation therapy with surgical resection (quality improvement measure)
Post breast conservation irradiation
Combination chemotherapy for hormone receptor negative
Adjuvant hormonal therapy for hormone receptor positive
Breast conserving surgery rate (surveillance measure)
Investigators can apply for a disease site-specific Participant User File (PUF).
Used to review and advance the quality of cancer care through analysis of cases reported to the NCDB.
Promotes retention of physicians at your facility.
International and national presentations, and peer-reviewed publications.
178 applicants in 2013.
Purpose: Informs programs about incomplete data in abstracts.
Content of Completeness Reports
Aggregates and compares:
Assist with product line analyses and program assessments:
Unadjusted Survival Rates by Stage
Non–Small-Cell Lung Cancer
“Driven by Highest Standards, Better Outcomes”